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Abstract
Introduction: Thyroid nodules not detected in palpation but diagnosed following a radiological procedure or during surgery are called
thyroid incidentalomas.
We designed this study to investigate the prevalence of sonographic thyroid incidentaloma in Isfahan, Iran, for the first time.
Material and methods: By a multistage cluster sampling method, 2523 adults were selected randomly. From this group, 2045 had normal
thyroid examination. 234 out of the 2045 were selected randomly for thyroid sonography. Thyroid stimulating hormone (TSH), urinary
iodine concentrations (UIC) and antithyroid antibodies were measured.
Results: The prevalence of thyroid incidentaloma was 13.2% [Confidence interval (CI) 95% = 8–18]. The average age of subjects with and
without incidentaloma was 46.1 (12.4) and 38.4 (12.1), respectively (P = 0.002). It was more prevalent in females than in males (19% vs. 10%)
[Odds ratio (OR) = 2.59, CI 95% = 1.17–5.76, P value (P) = 0.01]. Median UIC in the incidentaloma group (14 µg/dl) was significantly lower
than in the group of subjects without nodules (20 µg/dl) (OR = 0.9, CI 95% = 0.91–0.99, P = 0.02). There was no difference in the levels of
TSH and antithyroid antibodies between the two groups (P > 0.05).
Mean diameter of nodules was 8.14 (3.43) mm.
Conclusions: The prevalence of thyroid incidentaloma was 13.2% in Isfahan. It was higher in females than males and increased with age.
(Pol J Endocrinol 2008; 59 (4): 316–320)
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Streszczenie
Wstęp: Incidentalona to guzki tarczycy niewykrywalne palpacyjnie, lecz zdiagnozowane przypadkowo podczas badania obrazowego lub
zabiegu chirurgicznego. Celem badania było określenie po raz pierwszy częstości incidentaloma wykrywanych w badaniu sonograficznym
w populacji irackiego miasta Isfahan.
Materiał i metody: Metodą wielostopniowego losowania zespołowego wybrano grupę 2523 dorosłych osób. Spośród 2045 osób, u których
nie stwierdzono zmian w badaniu palpacyjnym, wytypowano losowo 234 osoby do badania sonograficznego tarczycy. Oznaczono u nich
również stężenie hormonu tyreotropowego (TSH, thyroid stimulating hormone), stężenie jodu w moczu (UIC, urinary iodine concentration)
oraz przeciwciała przeciwtarczycowe.
Wyniki: Incidentaloma tarczycy wykryto u 13,2% badanych (95% przedział ufności [CI] = 8–11). Średni wiek osób, u których wykazano
obecność guzków wynosił 46,1 (± 12,4) lat, natomiast osób bez guzków — 38,4 (± 12,1) lat (p = 0,002). Incidentaloma występowały częściej
u kobiet niż u mężczyzn (19 vs. 10%; iloraz szans [OR] = 2,59; 95% CI = 1,17–5,76; p = 0,01). Obie grupy nie różniły się pod względem
stężeń TSH i przeciwciał przeciwtarczycowych (p > 0,05).
Średnica guzków wynosiła średnio 8,14 (± 3,43) mm.
Wnioski: Częstość incidentaloma tarczycy w populacji Isfahanu wynosiła 13,2%; była większa u kobiet niż u mężczyzn i wzrastała z wiekiem.
(Endokrynol Pol 2008; 59 (4): 316–320)
Słowa kluczowe: guzki tarczycy, ultrasonografia, Iran, osoby dorosłe
Introduction
Thyroid nodule is a common problem. Approxima-
tely 4–10% of people in the United States have a palpa-
ble thyroid nodule [1]. In a study, in Los Angeles, 67%
of 97 persons with no past or family history of thyroid
disease had thyroid nodules in sonography (regardless
of thyroid examination status) [2].
Thyroid nodules are mostly benign. However, their
diagnosis, treatment and follow up are essential to rule
out thyroid cancer [3].
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The most common method to diagnose thyroid no-
dule is palpation. This detection depends on various
factors such as its size and location and the patient’s
neck anatomy. The diagnosis may be underestimated,
especially when the nodule diameter is less than 1 cm
[4]. Nodules not diagnosed by patients nor physicians
but detected during radiological procedures, neck and
thoracic surgeries or whole body nuclear scan are cal-
led thyroid incidentalomas [5].
Sonography is a radiological procedure that can re-
veal many small impalpable nodules (> 3 mm) [6]. So-
nography can also detect predictors of malignant no-
dules such as hypoechogenicity and calcification [7].
The prevalence of thyroid microcarcinoma, detec-
ted incidentally in surgery or autopsy, is 0.5% to 28.4%
[8, 9]. Therefore, the correct approach to thyroid inci-
dentaloma is important.
The prevalence of thyroid incidentaloma has been
reported to be 13.4% in Seoul [10], 14.8% in the Gdansk,
Sopot and Gdynia agglomeration [11] and 18.5% in Ta-
ipei [12].
We designed this study to investigate the prevalence of
thyroid incidentaloma and its clinical, biochemical and so-
nographic characteristics in a population-based study in Is-
fahan, a big centrally located city in Iran, with two million
[1 986,542 in 2006 (men 1 017,940, women 968,602)].
Material and methods
In a cross sectional study, 2600 Isfahani adults (> 20 years)
were selected by multistage cluster sampling method.
At the first stage, we selected 40 blocks on the city map
randomly.
Then, we asked the Post Office for the addresses of
all the homes in each block.
We then selected 960 addresses from the list (24 ho-
mes in each block) at random. In this way, 2600 adult
people were invited to take part in the study. 2523 out
of the 2600 people, mean age 39 (12.4) years, range:
20–86 years, 1275 males (50.5%) and 1248 females
(49.5%), accepted our invitation and came for examina-
tion and testing at the Isfahan Endocrine and Metabo-
lism Research Center (IEMRC), according to a preplan-
ned appointment between January and April 2006 (po-
sitive invitation response rate 97%).
Demographic data and history of thyroid disorders
and medications were obtained for each person and
thyroid examination was carried out. Their past medi-
cal documents were observed carefully.
Of the 2523 studied cases, 2045 subjects had normal
thyroid in physical examination. From these outwar-
dly normal cases, 300 were invited, randomly, for so-
nography. However, just 234 out of the 300 invited pe-
ople came for sonography. The mean age of people who
underwent sonography was 39.4 (12.4) years with a ran-
ge of 20–71 years.
This study was in accordance with the ethical stan-
dards of the IEMRC and Isfahan University of Medical
Sciences committees on human experimentation, and
with the 3rd edition of the Guidelines on the Practice
of Ethical Committees in Medical Research issued by
the Royal College of Physicians of London.
TSH concentration was measured in all 234 people,
urinary iodine concentration in 200 people and antithy-
roid peroxidase antibody (Anti TPO) and antithyroglo-
bulin antibody (Anti Tg) in 40 out of 234 people.
Normal range of TSH concentration was 0.3–4 mU/L.
Anti Tg and Anti TPO measurements greater than
100 IU/ml and 75 IU/ml, respectively, were considered
as positive. The normal range of urinary iodine con-
centration was 10–30 µg/dl and those outside this ran-
ge were supposed to be abnormal (UIC < 10 µg/dl was
defined as urinary iodine deficiency, and UIC > 30 µg/
dl was considered as iodine excess).
TSH concentration was measured by IRMA (Kavo-
shyar kits, Tehran, Iran) (Intra-assay and inter-assay
coefficient variation (CV) were 1.5% and 1.9%, respec-
tively). Anti TPO and Anti Tg were measured by Rapid
Enzyme-Linked ImmunoSorbent Assay (ELISA) (Gene-
sis Diagnostic Company). Intra-assay and inter-assay CV
for Anti TPO were 7% and 5%, respectively, and less
than 12% for Anti Tg. Urinary iodine level was assayed
by digestion method.
Thyroid ultrasonography was performed by HS-
2000 Honda ultrasound equipment with a 7.5 megahertz
(MHZ) linear probe. Sonographers were blind of thy-
roid physical examination status. People were exami-
ned in a supine position with hyper-extended neck by
one of two radiologists. Transverse (X), sagittal (Y) and
anteroposterior (Z) lengths of right and left lobes were
measured and volumes (V) calculated by three-dimen-
sional ellipsoid formula (V = p/6 × X × Y × Z) and
expressed in millilitres [13]. The sum of the volumes of
both lobes was taken as the thyroid volume (TV).
The isthmus was not taken into account in thyroid
volume calculation. Thyroid volume, number of nodu-
les (if any), the greatest diameter and echogenicity of
the nodule, as well as its calcification, were reported.
Statistical analysis
Anti Tg, Anti Tpo, TSH and urinary iodine concentra-
tion were not normally distributed and were recorded
as median (range) and compared by Mann-Whitney test
in the groups with and without incidentaloma.
Normally distributed data (age, nodule size and thy-
roid volume) were recorded as mean and standard de-
viation. They were compared between the two groups
by t-test.
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Chi-square test was used to compare the two gro-
ups in terms of gender and parity history.
To compare the data of males and females, we ente-
red age as a covariate in Uni-variate general linear model.
Fisher exact test was used to compare abnormal TSH
levels, positive Anti Tg and Anti TPO.
Statistical analysis was carried out using SPSS so-
ftware, version 13. P-values less than 0.05 were consi-
dered statistically significant.
Results
The characteristics of the 234 adults with normal thyro-
id examination who underwent sonography are shown
in Table I.
Mean age of these people was 39.4 (12.4) years with
the range of 20–71 years. Mean age of males was
40.7 (11.8) years vs. 37.1 (13.1) years for females (OR =
= 1.02, CI 95% = 1–1.05, P = 0.04).
The thyroid nodule prevalence following sonogra-
phy in 234 people with normal thyroid examination was
13.2% (CI 95% = 8–18). The prevalence of thyroid inci-
dentaloma in our study was higher in females than
males. However, it was not statistically significant (19%
vs. 10%, respectively, P = 0.05).
We entered age as covariate in the analysis and fo-
und that the prevalence of thyroid incidentaloma was
higher in women after adjusting for age (OR = 2.59,
CI 95% = 1.17–5.79, P = 0.01).
In women with thyroid incidentaloma, parity histo-
ry was higher than in those without (OR = 11.1, CI 95%
= 1.39–89.3, P = 0.001).
Twenty-eight percent of women with parity histo-
ry and 4% of those without had thyroid incidentaloma
(OR = 11.1, CI 95% = 1.39–89.3, P = 0.001). The mean
of the parity numbers was 3.4 (2) and 3 (1.7) in people
with and without incidentaloma, respectively (P = 0.4).
TSH level was not significantly different between
the healthy and incidentaloma groups [1.9 mU/L (0.3–
–4.8) vs. 1.8 mU/L (0.1–5.2), P = 0.5].
Abnormal TSH concentrations in two people with
thyroid incidentaloma was 4.7 mU/L and 5.2 mU/L. In
the healthy group, it was 0.1mU/L in one person and
between 4.2 mU/L and 5.1 mU/L in five people.
The median urinary iodine concentration was
18.3 mg/dl. Its range was 1.8–42 µg/dl. In the incidentaloma
group, 5 people (18.5%) were iodine deficient (UIC <
< 10 mg/dl), 20 (74%) were normal and 2 (7.4%) had
iodine excess (UIC > 30 mg/dl). In those without nodu-
les, iodine deficiency, sufficiency and excess were obse-
rved in (n = 30) (17.3%), (n = 112) (64.8%) and (n = 31)
(17.9%) people, respectively. Urinary iodine status was
not different between the two groups (P = 0.2).
The sonographic characteristics of thyroid nodules
in the people with thyroid incidentaloma are shown in
Table II.
None of the thyroid incidentalomas in our population
had a diameter of more than 1.5 cm. A nodule diameter of
between 1–1.5 cm was observed in only 23.8% of patients.
Discussion and conclusions
The prevalence of thyroid incidentaloma was 13.2 % in
our study (CI 95% = 8–18), which was similar to pre-
Table I. Comparison between characteristics of adult Isfahani population with and without thyroid incidentaloma in 2006
Tabela I. Porównanie parametrów demograficznych i laboratoryjnych dorosłych mieszkańców Isfahanu, u których wykryto
lub niewykryto incidentaloma tarczycy w 2006 roku
Characteristics With Nodule (n = 31) No Nodule (n = 203) P-Value
Female  16 (51.6%) 68 (33.5%) 0.01
Age (year) 46.1 (12.4) 38.4 (12.1) 0.02
Parity History in females 15 (93.7%) 40 (58.8%) 0.001
TSH [mU/L] 1.9 (0.3–4.8) 1.8 (0.1–5.2) 0.5
Anti TPO [IU/ml] 3.6 (0.7–23) 3.8 (1–555) 0.6
Anti Tg [IU/ml] 4.5 (1–221) 9.1 (2–756) 0.6
Abnormal TSH 2 (6.4%) 6 (2.9%) 0.5
Positive Anti TPO Ab **0 (0%) *2 (15.4%) 0.1
Positive Anti Tg Ab **1 (3.7%) *2 (15.4%) 0.2
Urinary iodine £14 (2–40) § 20 (1.8–42) 0.02
Iodine deficiency 5 (18.5%) 30 (17.3%) 0.5
Thyroid Volume [ml] 11.9 (5.7) 9.8 (3.7) 0.001
*27 out of 31 had Anti TPO and Anti Tg measurement; **13 out of 203 had Anti TPO and Anti Tg measurement; £ 27 out of 31 had urinary iodine
measurement; § 173 out of 203 had urinary iodine measurement; Data were recorded as number (percent) or median (range) or mean (standard
deviation); TSH — Thyroid Stimulating Hormone, Anti Tg Ab — Anti Thyroglobulin antibody, Anti TPO Ab — Anti Thyroid Peroxidase antibody
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(OR = 0.9, CI 95% = 0.91–0.99, P = 0.02), although
both groups were iodine sufficient. Urinary iodine
concentrations were 14 µg/dl and 20 µg/dl in people
with and without thyroid incidentalomas, respective-
ly. Thyroid nodule prevalence is higher in iodine de-
ficient areas [4].
It seems that lower urinary iodine concentration in
the incidentaloma group could explain the develop-
ment of nodules. However, urinary iodine concentra-
tion reflects the iodine intake on the day of urinary col-
lection. It cannot be interpreted as the long-term status
of iodine intake, which could have an effect on thyroid
nodule development [18].
In another study, performed on 4649 people, thyro-
id volume was 11.9 ml in areas with mild iodine defi-
ciency. This increased to13.5 ml in areas of moderate io-
dine deficiency [19]. In the present study, thyroid volu-
me was higher in the incidentaloma group [11.9 (5.7) ml
vs. 9.8 (3.7) ml, OR = 1.1, CI 95% = 1.02–1.21, P = 0.001].
According to the published data, there is a correla-
tion between thyroid volume and iodine intake status
[20]. However, greater thyroid volume among people
with incidentaloma could be expected.
In our study, multinodular goitre was observed in
29% of subjects in the incidentaloma group. This result
is higher than in some similar studies. In Taipei it was
3% [12] and in the Gdańsk, Sopot and Gdynia agglo-
meration it was 12% [11]. However, it was lower than
that reported in Turkey (48%) [9].
In our study, 58% of thyroid incidentalomas were
hypoechogenic, and 29% were both hypo & hypere-
chogenic (multiple nodules). In Italy, reported levels are
58% and 8%, respectively [21].
In conclusion, the prevalence of thyroid incidenta-
loma was 13.2% in Isfahan. It was more prevalent in
women and older people, and it increased with parity
history. In the incidentaloma group, the thyroid volu-
me was higher and urinary iodine concentration was
lower than in the group of healthy subjects.
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vious studies; 13.4% in Seoul [10]. 8% in the Gdańsk,
Sopot and Gdynia agglomeration [11] and 18.5% in Ta-
ipei [12]. None of the nodules had a diameter of more
than 1.5 cm. We can indirectly conclude that the physi-
cal examination in our study was done precisely. As was
expected, thyroid incidentaloma was observed more
often in older people (OR = 1.05, CI 95% = 1.02–1.08,
P = 0.02). Age has also been considered a risk factor for
thyroid nodule development in other studies [5, 11, 12].
By entering age as covariate in data analysis, the preva-
lence of thyroid incidentaloma was higher in females than
males (OR = 2.59, CI 95% = 1.17–5.79, P = 0.01). This
was in accordance to some other studies [11, 14].
A history of parity was observed more frequently in
women with thyroid incidentaloma (93.7% vs. 58.8%).
However, 28% of women with delivery history had thy-
roid nodules. Just 4% of nulliparus women (with no
delivery history) had nodules, in our study. These fin-
dings are similar to a study conducted in Germany, in
which it was reported that 25.1% of women with a hi-
story of parity had thyroid incidentalomas [15]. This
could be due to the increased need for iodine during
pregnancy.
In the present study, the number of deliveries had
no correlation with the presence of thyroid incidenta-
loma. It is contrary to a Chinese study, which reported
a positive correlation [14].
TSH levels were not significantly different between
the healthy and incidentaloma groups [1.9 (0.3–4.8) mU/L
vs. 1.8 (0.1–5.2) mU/L, P = 0.5]. Thyroid function was
normal in patients with thyroid nodule [16, 17].
There was no significant difference between heal-
thy subjects and those with incidentaloma with regard
to auto-immune markers (Anti Tg & Anti TPO), in the
present study. However, as antithyroid antibodies were
measured in only 13 out of 203 healthy people, this conc-
lusion may not be accurate.
The median level of urinary iodine concentration
was significantly lower in the incidentaloma group
Table II. Characteristics of nodule in Isfahani adults with
thyroid incidentaloma in 2006*
Tabela II. Charakterystyka guzków incidentaloma tarczycy
wykrytych u dorosłych mieszkańców Isfahanu w 2006 roku
Nodule Characteristics n (%)
Multiple nodule 9 (29%)
Single nodule 22 (71%)
Hypoechogenicity 18 (58%)
Both hyper- and hypoechogenicity 9 (29%)
*Mean and standard deviation of nodule diameter was 8.14 (3.43) ml
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